GSK has upgraded its longstanding alliance ... that it has signed a non-binding memorandum of understanding with South Africa-based Afrigen Biologics to support the development of an mRNA vaccine ...

So far, cabotegravir LA has been approved in the US, Australia, Zimbabwe, South Africa, and Malawi, said GSK.

We are always keen to speak to new individuals and organisations who support our ambitions for Africa. In 2015, we launched a five year partnership with GSK to provide analytical training for ...

The US Food and Drug Administration (FDA) approved British drug maker GSK’s combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company ...